These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 11758577)
21. National origins of new drugs. Kneller R Nat Biotechnol; 2005 Jun; 23(6):655-6. PubMed ID: 15940228 [No Abstract] [Full Text] [Related]
22. Insulin has never become a cheap generic drug in the US because of companies' small changes to "evergreen" the patent. Mayor S BMJ; 2015 Mar; 350():h1535. PubMed ID: 25794503 [No Abstract] [Full Text] [Related]
24. The effect of generic competition on the price of brand-name drugs. Lexchin J Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552 [TBL] [Abstract][Full Text] [Related]
25. Old drugs, new uses: solving a Hatch-Waxman patent predicament. McPhie DC Food Drug Law J; 2004; 59(1):155-68. PubMed ID: 15190929 [No Abstract] [Full Text] [Related]
26. Patent infringement. Generic HIV drugmaker's patent claim is time-barred. AIDS Policy Law; 2003 Aug; 18(16):6. PubMed ID: 14626916 [No Abstract] [Full Text] [Related]
27. US states file lawsuit against Bristol-Myers Squibb. McCarthy M Lancet; 2002 Jun; 359(9323):2092. PubMed ID: 12086769 [No Abstract] [Full Text] [Related]
29. Market exclusivity after a prescription to nonprescription drug switch: striking the right balance between innovation and competition. Kraushaar KJ Food Drug Law J; 1999; 54(2):243-4. PubMed ID: 11758581 [No Abstract] [Full Text] [Related]
30. Current issues in the pioneer versus generic drug wars. Safir PO Food Drug Law J; 1995; 50(2):335-9. PubMed ID: 10343002 [No Abstract] [Full Text] [Related]
35. Lowering the cost of prescription drugs. Jindal B J La State Med Soc; 2003; 155(1):51. PubMed ID: 12656276 [No Abstract] [Full Text] [Related]
36. Reference pricing of pharmaceuticals. Brekke KR; Königbauer I; Straume OR J Health Econ; 2007 May; 26(3):613-42. PubMed ID: 17188769 [TBL] [Abstract][Full Text] [Related]
37. A precarious balancing act--the role of the FDA as protector of public health and industry wealth. McCabe AR Suffolk Univ Law Rev; 2003; 36(3):787-819. PubMed ID: 16493844 [No Abstract] [Full Text] [Related]